GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Procter & Gamble Health Ltd

P&G Health Q2 FY27 Sales Up 18% to ₹376 Crores, PAT Rises 26% to ₹112 Crores

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 02 Nov 2026, 02:53 PM IST  ·  BSE ID: b05f21cc-4997-4464-a726-81b416da7597
View Original BSE Filing (PDF)
💡
In Simple Terms
Procter & Gamble Health announced its Q2 FY27 results, showing sales up 18% to ₹376 crores and profit up 26% to ₹112 crores.
🤖 AI Summary
  • Procter & Gamble Health Ltd. reported sales of ₹376 crores for Q2 FY27, an 18% increase year-over-year.
  • Profit After Tax (PAT) for the quarter ended September 30, 2026, stood at ₹112 crores, up 26% year-over-year.
  • Sales growth was driven by strong brand fundamentals, superior retail execution, and positive consumer response to innovations.
  • PAT growth resulted from increased sales and productivity improvements across the entire value chain.
  • The company maintains double-digit topline and bottom-line growth momentum, as per managing director Milind Thatte.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Sales for Q2 FY27
₹376 crores
18%
Profit After Tax (PAT) for Q2 FY27
₹112 crores
26%
🏢 How This Affects the Company
📈
Business Impact
The company demonstrated continued momentum in its core business with increased sales driven by brand strength and market execution, indicating sustained consumer adoption of its VMS products.
💰
Financial Impact
Growth in both sales and Profit After Tax suggests improved financial performance and operational efficiency, contributing to positive earnings for the quarter.
⚙️
Operational Impact
Strong retail execution, new consumer communication, and enhanced go-to-market and supply chain capabilities point to effective operational strategies.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results press release.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with reported sales at ₹376 crores and PAT at ₹112 crores for Q2 FY27, reflecting operational outcomes.
🔍
Management Signal
Management's statement emphasizes delivering balanced growth and value creation, focusing on a portfolio of quality brands, superiority, and productivity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — monitor sales and PAT growth rates for continuity.
Any further management commentary on productivity initiatives and retail execution.
Updates on new product innovations and their market reception.
LOW RISK The filing reports strong financial results with no apparent new risks or adverse developments.
💡 Investor Takeaway
Procter & Gamble Health Ltd. reported Q2 FY27 sales of ₹376 crores, up 18% year-over-year, and Profit After Tax (PAT) of ₹112 crores, a 26% increase. This continues a trend of double-digit growth in both revenue and profit.
⚖️ Strengths & Concerns

✅ Positives

  • Sales increased by 18% to ₹376 crores for Q2 FY27, indicating robust demand and effective market strategies.
  • Reported Profit After Tax (PAT) rose by 26% to ₹112 crores, reflecting improved profitability and productivity across operations.
📅 Company Track Record
In Q1 FY27, P&G Health reported sales up 7% to ₹356 crores and PAT up 45% to ₹96 crores, which included a ₹3,180 Lakhs property sale gain. The current Q2 FY27 results show continued sales growth and a more operationally driven PAT increase.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What were Procter & Gamble Health's sales for Q2 FY27?
Procter & Gamble Health Ltd. reported sales of ₹376 crores for the quarter ended September 30, 2026, which is an 18% increase compared to a year ago.
What was the Profit After Tax (PAT) for Procter & Gamble Health in Q2 FY27?
The Profit After Tax (PAT) for Procter & Gamble Health Ltd. in Q2 FY27 was ₹112 crores, representing a 26% increase over the previous year.
What drove the sales growth for Procter & Gamble Health in Q2 FY27?
Sales growth was driven by strong brand fundamentals, superior retail execution, positive consumer response to new innovations, and strengthened go-to-market capabilities.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.